Whitehawk Therapeutics (WHWK) Leases (2019 - 2024)
Historic Leases for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q4 2024 value amounting to $787000.0.
- Whitehawk Therapeutics' Leases fell 3267.75% to $787000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $787000.0, marking a year-over-year decrease of 3267.75%. This contributed to the annual value of $787000.0 for FY2024, which is 3267.75% down from last year.
- Per Whitehawk Therapeutics' latest filing, its Leases stood at $787000.0 for Q4 2024, which was down 3267.75% from $886000.0 recorded in Q3 2024.
- Whitehawk Therapeutics' Leases' 5-year high stood at $1.7 million during Q2 2022, with a 5-year trough of $9452.0 in Q2 2021.
- For the 5-year period, Whitehawk Therapeutics' Leases averaged around $829310.9, with its median value being $886000.0 (2024).
- As far as peak fluctuations go, Whitehawk Therapeutics' Leases plummeted by 9176.04% in 2021, and later surged by 1738836.23% in 2022.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Leases stood at $89761.0 in 2020, then soared by 520.54% to $557000.0 in 2021, then skyrocketed by 173.25% to $1.5 million in 2022, then dropped by 23.19% to $1.2 million in 2023, then tumbled by 32.68% to $787000.0 in 2024.
- Its last three reported values are $787000.0 in Q4 2024, $886000.0 for Q3 2024, and $982000.0 during Q2 2024.